Detailed price information for Replimune Group Inc (REPL-Q) from The Globe and Mail including charting and trades.

As India prepares for a new budget session, it is important to recognise clean energy as the backbone of infrastructure ...

Antigravity is a proprietary fork of VS Code that tightly integrates Google's Gemini 3 models, giving you an edge if you want ...

WOBURN, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ...

North Macedonia's drug maker Replek said on Friday it increased its pharmaceutical segment sales revenue by 8% year-on-year ...

Shares of Replimune Group REPL have surged 131.1% over the past three months, fueled by positive regulatory updates. In October, the FDA accepted the resubmission of the biologics license application ...

The uMkhonto we Sizwe Party (MKP) on Monday announced a shakeup in its leadership, with the immediate appointment of Brian ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...

In September, Replit completed a $250M funding round that gave it a $3B valuation. That round was led by Prysm Capital and ...